Posted by Michael Wonder on 17 Jan 2025
International collaboration provides new guidance on the use of surrogate outcomes in cost effectiveness analysis
17 January 2025 - Recommendations will help organisations that evaluate new drugs establish whether their use will result in longer-term benefits for patients.
NICE, in collaboration with other international health technology assessment agencies, has published a new report which offers guidance on best practice for using surrogate outcomes in health economic models to guide health technology assessment decisions.
